{"disease":{"id":"glomerulonephritis-iga","name":"glomerulonephritis iga"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT06858319","title":"Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03357653","title":"Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":174,"lead_sponsor_name":"Ewha Womans University","has_results":false},{"nct_id":"NCT02523768","title":"Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":117,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT05797051","title":"Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT04020328","title":"Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Shenzhen Second People's Hospital","has_results":false},{"nct_id":"NCT03841448","title":"A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Alnylam Pharmaceuticals","has_results":true},{"nct_id":"NCT06797518","title":"Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05383547","title":"Bortezomib for Treating Glomerular Diseases","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT04663204","title":"A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":12,"lead_sponsor_name":"University of Leicester","has_results":false},{"nct_id":"NCT04342325","title":"The Clinical Trial of ADR-001 for IgA Nephropathy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Nagoya University","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}